WebbSCYNEXIS recently announced new strategic direction to refocus its resources on the clinical development of ibrexafungerp for severe, hospital-based indications.Ivor … Webb20 okt. 2024 · All forward-looking statements contained in this press release speak only as of the date on which they were made. SCYNEXIS undertakes no obligation to update …
Press Releases - ir.scynexis.com
Webb31 mars 2024 · JERSEY CITY, N.J., March 31, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX ), a biotechnology company pioneering innovative medicines to … WebbPress Releases. Official Publications. Sector news. Communiqués de presse de la société GSK PLC. 04/12. Gsk : Q1 2024 pre announcement aide memoire. PU. 03/31. GSK and … new condos wilton manors
GSK and SCYNEXIS Announce an Exclusive Agreement to …
WebbFör 1 dag sedan · JERSEY CITY, N.J., April 13, 2024 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to … WebbFor more information, visit www.scynexis.com. CONTACT: Investor Relations Irina Koffler LifeSci Advisors Tel: (646) 970-4681 [email protected]. Media Relations … Webb13 apr. 2024 · SCYNEXIS, Inc. today announced the presentation of interim data across a diverse array of infection types from its ongoing Phase 3 FURI and CARES studies, as … newcon energy